Jeffrey Goldsmith, Past President of the American Society of Addiction Medicine

Dr. Goldsmith was in private practice from 1981-1994.  In 1994 Dr. Goldsmith joined the VA hospital fulltime and he currently works in the Buprenorphine Treatment Clinic and Dual Diagnosis Clinic in Cincinnati VAMC.

From 1994-2009, Dr. Goldsmith worked in Dual Diagnosis Services and research with the Clinical Trials Network. He was an active member of Cincinnati’s NIDA research group, which has run many clinical trials for NIDA, including the pivotal study CS1008 of buprenorphine/naloxone for opiate addiction.  Dr Goldsmith created an integrated Primary Care Mental Health program with the director of primary care. In 1995, Dr. Goldsmith developed an ACGME accredited Addiction Psychiatry Fellowship and the following year was funded by the Dept. of Veterans Affairs for a two year Addiction Medicine Research Fellowship. He was addiction fellowship director from 1989 to 2007 and continues to teach in the two addiction fellowships.  He teaches Psychiatry Residents still.

Dr. Goldsmith joined ASAM in 1984, became ASAM certified in 1986 and got his CAQ in Addiction Psychiatry in 1994.  He is Immediate Past President of ASAM and a member of the Board of Directors.